Search

Chronic kidney failure patients treated by hemodialysis therapy should be consistent in participating in dieting program in order to forestall the incidence of nutrition deficiency, liquid and electrolyte imbalance, and the incidence of the excessive accumulation of metabolism residual. Compliance in dieting program is one of the factors which contribute to the success or failure in hemodialysis therapy. The objective of the research was to find out some factors which influenced compliance in dieting of chronic kidney failure patients who got hemodialysis therapy in Hemodialysis Room of RSUD dr. Pirngadi, Medan. The research used descriptive method with cross sectional design. The samples were 35 respondents, taken by using purposive sampling technique. The instruments of the research were questionnaires and food recall. The result of the research showed that 19 respondents (54.3%) did not quite understand the instruction, 26 respondents (74.3%) had good interaction, 21 respondents (60%) lack of support, 31 respondents (88.6%) did not comply with dieting program, and 4 respondents (11.4%) complied with dieting program. The factor which influenced the compliance of the majority of patients was interaction quality. Patients had good understanding in instruction, good interaction quality, and family support. Only a small number of patients complied with dieting. Patients’ awareness of diet is very important. The majority of patients did not comply with dieting program.

Seborrheic dermatitis is a common, chronic, relapsing inflammatory skin disorder that manifests as erythema, scaling and pruritus in sebum gland-rich areas of the skin. The objective of this article is to evaluate the clinical efficacy of pimecrolimus 1% cream in the treatment of seborrheic dermatitis compared with corticosteroids, antimycotics, placebo or no intervention. Pimecrolimus 1% cream appears to be a well-tolerated and effective treatment for seborrheic dermatitis. It has comparable efficacy, in terms of decreasing severity of erythema, scaling and pruritus, to the standard treatments: topical corticosteroids and antimycotics. However, future studies with more standardized measures of treatment outcome are recommended. More studies may also be conducted to further evaluate pimecrolimus 1% cream as a long-term maintenance therapy for seborrheic dermatitis.

Acute radiation dermatitis (ARD) is a common side effect of radiation therapy and is characterized by erythema, dry desquamation or moist desquamation. This wet desquamation is a very painful condition for the patient and often leads to interruption of radiotherapy. The objective of this article is to assess the efficacy of topical corticosteroids in the prevention of ARD compared with placebo, other topical medication or no treatment. The prophylactic application of topical corticosteroid among patients undergoing radiotherapy appears to significantly reduce the incidence of ARD, specifically moist desquamation, compared with other treatments. Future trials with a more standardized measure of radiation dermatitis grading are recommended. Further research may also be conducted to determine if a mildly potent, midpotent or super potent topical steroid will be more effective in preventing ARD.